Sep 27 |
High Growth Tech Stocks in the United States to Watch
|
Sep 25 |
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
|
Aug 26 |
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
Aug 26 |
Alvotech: Steady Progress Offers A Good Chance Of Upside
|
Aug 19 |
Alvotech Second Quarter 2024 Earnings: EPS: US$0.25 (vs US$0.83 in 2Q 2023)
|
Aug 17 |
Alvotech's (NASDAQ:ALVO) biggest owners are private equity firms who got richer after stock soared 19% last week
|
Aug 16 |
Alvotech (ALVO) Q2 2024 Earnings Call Transcript
|
Aug 16 |
Alvotech 2024 Q2 - Results - Earnings Call Presentation
|
Aug 15 |
Alvotech GAAP EPS of -$0.61, revenue of $236M
|
Aug 15 |
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
|